【中图分类号】 R544.1 【文献标识码】 ADOI：10.12114/j.issn.1007-9572.2024.0376

    Research Progress on Blood Pressure Management of Vascular Endothelial Growth Factor SignalingPathwayInhibitor-relatedHypertension

    SUIHongping’，LI Tingting’，JIANGTongtong'，XIAYunlong2，SHI Tieyingl 1.DepartmentofNursing，theFirstAfliated Hospitalof Dalian Medical University，Dalian116Oll，China 2.DepartmentofCardiology，theFirstAfliated HospitalofDalian Medical University，Dalianl16ol1，China *Corresponding author：SHI Tieying，Chiefnurse/Doctoral supervisor； E -mail：sty11177@163.com

    【Abstract】Vascularendothelial growth factor signaling pathway(VSP)inhibitors have gradually increased and beenwidelyusedrecently，withahigh incidenceofinducing hypertensionadverse events.VSPinhibitorinduced hypertension isdiffculttodiagnoseinatimelyandthemanagementofuncontrolledblood pressureisneglected，activebloodpressure managementstrategiesareessential.ThispapersummarizedthestatusofVSPinhbitorstreatmentanditsrelatedhypertension，as wellsthebloodpressremanagementstrategiesforVSPinibitor-relatedhypertension.Teimwastoincreasetheawaresof VSPinhibitor-relatedhypertensionamonghealthcareprofessonalsandprovidebloodpressuremanagementstrategiesforpatients using VSP inhibitors to improve blood pressure control and cardiovascular health. ......